Dronedarone in Pacemaker Patients With Paroxysmal Atrial Fibrillation.

Trial Profile

Dronedarone in Pacemaker Patients With Paroxysmal Atrial Fibrillation.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Dronedarone (Primary)
  • Indications Paroxysmal atrial fibrillation
  • Focus Therapeutic Use
  • Acronyms DROPPAF
  • Most Recent Events

    • 05 Apr 2012 European Clinical Trials Database reports actual initiation date as 2 Jul 2010.
    • 28 Mar 2012 Status changed from not yet recruiting to recruiting as reported by European Clinical Trials Database record.
    • 24 Feb 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top